Table 2.
UK-Windsor Framework vs. EU Regulations.
| Comparative analysis | UK Windsor framework | EU pharmaceutical regulations (EMA) |
|---|---|---|
| Regulatory Authority |
MHRA governs the regulation of medicinal products in UK including Northern Ireland (NI) It operates independently of EMA but maintains cooperation wherever applicable |
European Medicines Agency (EMA) oversees regulations of medicinal product across its member states |
| Marketing Authorisation |
All product licenses will be primarily considered to be UK wide All UK application must go through MHRA-specific approval process post Windsor Framework No automatic cross recognition with EMA, separate approval process required for products already authorised in EU |
Multiple pathways: Centralised, Decentralised, Mutual recognition and National procedure remains unchanged for market approval across all member states of EU |
| Pharmacovigilance |
Independent Pharmacovigilance system is followed by MHRA Yellow card scheme for reporting adverse event reporting (ADRs) |
EudraVigilance database for monitoring and reporting adverse event reporting (ADRs) across EU member states |
| Pricing and Reimbursement |
MHRA determines cost and reimbursement of medicines Separate pricing policies are available for entire UK |
Each EU member state determines pricing and reimbursement though EMA encourages transparency and cross border referencing of prices |
| Labelling | Windsor establishes new labeling (‘UK Only’) requirements in accordance with MHRA | Labelling requirements are established as per EMA directive |
| Regulatory Compliance | MHRA maintains a uniform compliance in Good Manufacturing Practice (GMP) inspections and safety reporting | EMA coordinates with all member states to ensure organized approach of regulation |
| Market Access and Trade |
Access to any authorised product is uniform throughout UK (including NI) Trade barriers cease to exist within the UK as facilitated in Windsor Framework |
Market access in EU single market is independent of authorisation by MHRA Trade barriers will come into existence only between EU and NI |